pharma news today glp-1 health obesity drugs october 2025 Outlook for obesity in 2025: more GLP-1 Drugs: 6 Things We've
Description
A small clinical trial showed that liraglutide reduced heroin cravings in humans, although this was an exploratory study and requires confirmation in larger samples (www.tinyurl.com/bde6h7cp)
Add the Precision Peptide Genetic Test at $99 as a one-time add-on after month one and the genetic-baseline-included totals still come in below Willow on the injection categories
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (PIONEER 6)
GLP-1 and Fatty Liver Disease (NAFLD/NASH) GLP-1RAs show promising benefits in: Hepatic steatosis reduction Weight loss-mediated liver improvement Improved insulin resistance Reduced inflammation These agents are likely to become central therapies in metabolic-associated steatotic liver disease (MASLD)
Its job is coordination
A number of studies highlight the importance of the gut-brain signaling in the regulation of alcohol intake (Crespi, 2010)
